Trebananib Completed Phase 1 Trials for Advanced Solid Tumors / Kidney Diseases / Impaired Renal Function Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT01331941A Pharmacokinetic Study of AMG 386 in Cancer Subjects With Normal and Impaired Renal Function
NCT00861419To Evaluate the Safety, Tolerability and Pharmacokinetics of AMG 386 When Used in Combination With AMG 706, Bevacizumab, Sorafenib, or Sunitinib.
NCT01992341AMG 386 Drug-Drug Interaction Study With Paclitaxel